Cor Pulmonale
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
The goals of treatment of cor pulmonale are 1) to reduce pulmonary arterial hypertension; 2) to optimize gas-exchange efficiency; and 3) to improve survival. These goals are achieved through long-term oxygen therapy, bronchodilator and vasodilator therapy, aggressive treatment of pulmonary infection, and anticoagulation. Selected patients may benefit from available surgical options.
References
1.
Hill N, Warburton R, Pietras L, Klinger J
. Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats. J Appl Physiol (1985). 1997; 83(4):1209-15.
DOI: 10.1152/jappl.1997.83.4.1209.
View
2.
Wanecek M, Rudehill A, Hemsen A, Lundberg J, Weitzberg E
. The endothelin receptor antagonist, bosentan, in combination with the cyclooxygenase inhibitor, diclofenac, counteracts pulmonary hypertension in porcine endotoxin shock. Crit Care Med. 1997; 25(5):848-57.
DOI: 10.1097/00003246-199705000-00022.
View
3.
MacNee W
. Predictors of survival in patients treated with long-term oxygen therapy. Respiration. 1992; 59 Suppl 2:5-7.
DOI: 10.1159/000196112.
View
4.
Kiely D, Cargill R, Lipworth B
. Angiotensin II receptor blockade and effects on pulmonary hemodynamics and hypoxic pulmonary vasoconstriction in humans. Chest. 1996; 110(3):698-703.
DOI: 10.1378/chest.110.3.698.
View
5.
Galie N, Ussia G, Passarelli P, Parlangeli R, Branzi A, Magnani B
. Role of pharmacologic tests in the treatment of primary pulmonary hypertension. Am J Cardiol. 1995; 75(3):55A-62A.
DOI: 10.1016/s0002-9149(99)80384-1.
View